Oncolytics Biotech
ONCY
#9264
Rank
ยฃ75.27 M
Marketcap
ยฃ0.71
Share price
-4.78%
Change (1 day)
2.74%
Change (1 year)

Oncolytics Biotech (ONCY) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ6.65 Million

According to Oncolytics Biotech 's latest financial reports the company has ยฃ6.65 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Oncolytics Biotech - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ8.85 M-57.15%
2023-12-31ยฃ20.66 M5.54%
2022-12-31ยฃ19.57 M-18.38%
2021-12-31ยฃ23.98 M33.53%
2020-12-31ยฃ17.96 M117.44%
2019-12-31ยฃ8.26 M4.26%
2018-12-31ยฃ7.92 M13.74%
2017-12-31ยฃ6.96 M-18.22%
2016-12-31ยฃ8.51 M-32.86%
2015-12-31ยฃ12.68 M41.61%
2014-12-31ยฃ8.95 M-42.22%
2013-12-31ยฃ15.5 M17.02%
2012-12-31ยฃ13.24 M-39.91%
2011-12-31ยฃ22.04 M-20.71%
2010-12-31ยฃ27.8 M38.72%
2009-12-31ยฃ20.04 M169.04%
2008-12-31ยฃ7.45 M-41.44%
2007-12-31ยฃ12.72 M5.07%
2006-12-31ยฃ12.1 M-39.84%
2005-12-31ยฃ20.12 M36.82%
2004-12-31ยฃ14.71 M64.48%
2003-12-31ยฃ8.94 M172.24%
2002-12-31ยฃ3.28 M-49.32%
2001-12-31ยฃ6.48 M-17.74%
2000-12-31ยฃ7.87 M303.65%
1999-12-31ยฃ1.95 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Aeterna Zentaris
AEZS
ยฃ20.87 M 213.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ7.44 B 111,647.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ12.38 B 185,914.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.65 B 24,732.80%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
ยฃ58.09 M 772.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
ยฃ0.73 B 10,906.62%๐Ÿ‡บ๐Ÿ‡ธ USA